Literature DB >> 7522106

What do advanced cancer patients know of their disease? A report from Italy.

P Pronzato1, G Bertelli, P Losardo, M Landucci.   

Abstract

The aim of this work was to investigate the awareness of diagnosis, prognosis and meaning of palliative treatment in Italian patients with advanced, incurable cancers. A group of 100 patients, referred to a Medical Oncology facility, were interviewed. Only 38 patients were aware of the malignant neoplastic nature of their disease. The remaining patients believed they had a benign neoplasia, non-neoplastic disease, or were unable to define their illness. No patient had a correct idea of the poor prognosis of the disease. Only 11.5% of 87 patients receiving chemotherapy had a correct perception of the palliative intent of the treatment, while most believed that the chemotherapy was "preventive". Dissatisfaction with the information received was expressed by a minority of patients. The awareness of diagnosis was better among women and patients with a higher educational background. Withholding the truth from cancer patients still seems very common in Italy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7522106     DOI: 10.1007/bf00365729

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  11 in total

1.  Truth telling to the patient.

Authors:  A Surbone
Journal:  JAMA       Date:  1992-10-07       Impact factor: 56.272

2.  [Telling the patient the diagnosis of cancer].

Authors:  T Doi
Journal:  Gan To Kagaku Ryoho       Date:  1989-04

3.  Cancer and communication: information-giving in an oncology clinic.

Authors:  P M Reynolds; R W Sanson-Fisher; A D Poole; J Harker; M J Byrne
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-02

4.  Words as scalpels: transmitting evidence in the clinical dialogue.

Authors:  S J Reiser
Journal:  Ann Intern Med       Date:  1980-06       Impact factor: 25.391

5.  The doctor-patient relationship: headed for impasse or improvement?

Authors:  P S Jensen
Journal:  Ann Intern Med       Date:  1981-12       Impact factor: 25.391

6.  What do gastroenterologists in Europe tell cancer patients?

Authors:  O O Thomsen; H R Wulff; A Martin; P A Singer
Journal:  Lancet       Date:  1993-02-20       Impact factor: 79.321

7.  Disclosure of breast cancer diagnosis: patient and physician reports. GIVIO (Interdisciplinary Group for Cancer Care Evaluation, Italy)

Authors:  P Mosconi; B E Meyerowitz; M C Liberati; A Liberati
Journal:  Ann Oncol       Date:  1991-04       Impact factor: 32.976

8.  Information and participation preferences among cancer patients.

Authors:  B R Cassileth; R V Zupkis; K Sutton-Smith; V March
Journal:  Ann Intern Med       Date:  1980-06       Impact factor: 25.391

9.  Cancer diagnosis disclosure in a Spanish hospital.

Authors:  J Estapé; H Palombo; E Hernández; M Daniels; T Estapé; J J Grau; N Viñolas; J M Mañé
Journal:  Ann Oncol       Date:  1992-06       Impact factor: 32.976

10.  Cancer patients' perceptions of their disease and its treatment.

Authors:  W J Mackillop; W E Stewart; A D Ginsburg; S S Stewart
Journal:  Br J Cancer       Date:  1988-09       Impact factor: 7.640

View more
  27 in total

1.  Discrepancy between treatment goals documentation by oncologists and their understanding among cancer patients under active treatment with chemotherapy.

Authors:  Varun Monga; Seth M Maliske; Hassan Kaleem; Sarah L Mott; Gideon K D Zamba; Mohammed Milhem
Journal:  Eur J Cancer Care (Engl)       Date:  2018-12-03       Impact factor: 2.520

Review 2.  Conceptualizing prognostic awareness in advanced cancer: a systematic review.

Authors:  Allison J Applebaum; Elissa A Kolva; Julia R Kulikowski; Jordana D Jacobs; Antonio DeRosa; Wendy G Lichtenthal; Megan E Olden; Barry Rosenfeld; William Breitbart
Journal:  J Health Psychol       Date:  2013-10-24

Review 3.  Minimally invasive palliative interventions in advanced lung cancer.

Authors:  Christopher Mallow; Margaret Hayes; Roy Semaan; Thomas Smith; Russell Hales; Roy Brower; Lonny Yarmus
Journal:  Expert Rev Respir Med       Date:  2018-06-19       Impact factor: 3.772

4.  Patients' understanding of clinical trials needs to be assessed in the context of understanding of overall goals of care.

Authors:  Jaclyn Yoong; Michael Jefford; Linda Mileshkin
Journal:  Support Care Cancer       Date:  2011-06-03       Impact factor: 3.603

5.  Male-female patient differences in the association between end-of-life discussions and receipt of intensive care near death.

Authors:  Rashmi K Sharma; Holly G Prigerson; Frank J Penedo; Paul K Maciejewski
Journal:  Cancer       Date:  2015-05-14       Impact factor: 6.860

6.  Lung cancer chemotherapy decisions in older patients: the role of patient preference and interactions with physicians.

Authors:  Regina Gironés; Dolores Torregrosa; José Gómez-Codina; Inma Maestu; Jose María Tenias; Rafael Rosell
Journal:  Clin Transl Oncol       Date:  2012-03       Impact factor: 3.405

7.  Patients' expectations about effects of chemotherapy for advanced cancer.

Authors:  Jane C Weeks; Paul J Catalano; Angel Cronin; Matthew D Finkelman; Jennifer W Mack; Nancy L Keating; Deborah Schrag
Journal:  N Engl J Med       Date:  2012-10-25       Impact factor: 91.245

8.  Disclosure preferences regarding cancer diagnosis and prognosis: to tell or not to tell?

Authors:  H Miyata; M Takahashi; T Saito; H Tachimori; I Kai
Journal:  J Med Ethics       Date:  2005-08       Impact factor: 2.903

Review 9.  Cancer information disclosure in different cultural contexts.

Authors:  Kyriaki Mystakidou; Efi Parpa; Eleni Tsilila; Emmanuela Katsouda; Lambros Vlahos
Journal:  Support Care Cancer       Date:  2004-03       Impact factor: 3.603

10.  Relationship between the prognostic expectations of seriously ill patients undergoing hemodialysis and their nephrologists.

Authors:  Melissa W Wachterman; Edward R Marcantonio; Roger B Davis; Robert A Cohen; Sushrut S Waikar; Russell S Phillips; Ellen P McCarthy
Journal:  JAMA Intern Med       Date:  2013-07-08       Impact factor: 21.873

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.